Thirumalaisamy Rathinavel

9PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanomaterialsMolecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 26, 2025
Correction: FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective.

R Thirumalaisamy, S Vasuki, S M Sindhu

|Aug 05, 2024
In vitro cancer cell line luminescence-based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells.

Kandasamy Chitra, Muthusamy Sureshkumar, Aiswarya Muraleedharan

|Mar 08, 2024
FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective.

R Thirumalaisamy, S Vasuki, S M Sindhu

|Nov 22, 2023
Green Synthesis and Characterization of Silver Nanoparticles from Eclipta alba and Its Activity Against Triple-Negative Breast Cancer Cell Line (MDA-MB-231).

Suresh Thanjavur Mani, P Jayakumar, Marimuthu E Pavithra

|Sep 12, 2022
Molecular insight of phytocompounds from Indian spices and its hyaluronic acid conjugates to block SARS-CoV-2 viral entry.

Karthika Rajamanickam, Thirumalaisamy Rathinavel, Velu Periyannan

|Mar 16, 2022
Molecular insights of hyaluronic acid - ethambutol and hyaluronic acid - isoniazid drug conjugates act as promising novel drugs for the treatment of tuberculosis.

R Thirumalaisamy, V Aroulmoji, Muhammad Nasir Iqbal

Pageof 2

Frequent Collaborators

4 joint publications

Muhammad Nasir Iqbal

2 joint publications

Suresh Kumarasamy

1 joint publications

V Aroulmoji

1 joint publications

Shreyas Saride